Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBP501 with Pemetrexed and Cisplatin in Solid Tumors and Mesothelioma
NCT00700336Phase 2Completed
- Sponsor
- CanBas
- Start
- May 2008
- Primary completion
- Jul 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBP-501 in malignant pleural mesothelioma (MPM), solid tumor, sponsored by CanBas. Started May 2008; status: completed.
02
Drugs
CBP-501
03
Conditions
malignant pleural mesothelioma (MPM)solid tumor
Beyond the preview
Go deeper on NCT00700336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700336.